For assaying plasma cholinesterase (EC 3.1.1.8) activity and phenotyping by means of dibucaine inhibition, we have compared a commercially available kit, in which butyrylthiocholine is used as substrate, with two reference methods, one using benzoylcholine and the other propionylthiocholine. With 50 different samples of three of the most common genetic variants, we could clearly differentiate the variants with benzoylcholine and dibucaine, whereas there was some overlap of the E1uE1UJand E1UE1aphenotypes with the other two substrates at 30 #{176}C. The phenotypes were better differentiated at 25 #{176}C, and in our hands the use of butyrylthiocholine was preferable to propionylthiocholine for phenotyping with dibucaine. The affinity of the usual and atypical homozygotes for fluoride with butyrylthiocholine gave an inverted response to the affinity of these variants for the anion with benzoylcholine. We suggest that this may be explained by the role of the chromogen or its products in the assay procedure with the thiocholine substrate. This includes the increasing demand by anesthetists for the assay of plasma cholinesterase (acyicholine acyihydrolase, EC 3.1.1.8) and the investigation of the genetic variants of the enzyme before the patient is given the muscle relaxant succinylcholine (suxamethonium, Scoline) (1). Clearly a simple method of assay is essential, and a colorimetric procedure functioning in the visible range of wavelengths is desirable.
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The ever-increasing use of automation in the clinical chemistry laboratory has resulted in requests for many specialized tests to become available as routine procedures. This includes the increasing demand by anesthetists for the assay of plasma cholinesterase (acyicholine acyihydrolase, EC 3.1.1.8) and the investigation of the genetic variants of the enzyme before the patient is given the muscle relaxant succinylcholine (suxamethonium, Scoline) (1). Clearly a simple method of assay is essential, and a colorimetric procedure functioning in the visible range of wavelengths is desirable.
The numerous methods available for the assay of plasma cholinesterase include the modified colorimetric procedure of Eliman et al. (2), which measures the sulfhydryl derivative of choline liberated by the enzyme from acetyithiocholine. The thiocholine produced by the enzymic hydrolysis reacts stoichiometrically with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) to yield a 5-thio-2-mtrobenzoate anion, which (11) (12) (13) .
We have attempted to evaluate the degree of comparison and selectivity for three of the substrates that have been recommended for the determination of cholinesterase activity in the clinical laboratory under recommended conditions. For reference, we chose benzoylcholine as substrate at 25 #{176}C (14) ; this was used in the original procedure and is still the most popular method (15) for phenotyping the cholinesterase variants with use of dibucaine (16) and fluoride (17) as differential inhibitors for the recognition of the variant phenotypes. The same inhibitors are used in the propionylthiocholine method performed at 37 #{176}C (10) but information is sparse on the use of these inhibitors with butyrylthiocholine as substrate. The International Federation of Clinical Chemistry has given considerable attention to the assay temperatures for enzymes and has recommended that assay at 30 #{176}C should become the standard procedure (18). It therefore seems desirable not only to assess the commercial kit at 30#{176}C but also to compare the results with those obtained with use of propionyithiocholine at the same temperature.
There is, however, some evidence that the cholinesterase variants are better differentiated at 25#{176}C (15) ; therefore, we determined enzyme activities and dibucaine numbers at 25#{176}C for all samples, using butyrylthiocholine as well as benzoylcholine as substrate.
Materials and Methods

Materials
Dibucaine was obtained as Cinchocaine hydrochloride from Ward Blenkinsop & Co. Ltd., Widnes, Cheshire, A8 8MB, U.K. Propionyithiocholine iodide was obtained from Sigma Chemical Co., Poole, Dorset, BH17 7NH, U.K. All other materials and chemicals were obtained from BDH Chemicals Ltd., Poole, Dorset, BH12 4NN, U.K.
All measurements were carried out with a Perkin-Elmer Model 402 recording spectrophotometer fitted with a "Multisampler" attachment.
The assays with benzoylcholine chloride and propionylthiocholine iodide were carried out in duplicate, but the butyrylthiocholine iodide assays were based on single determinations.
By venepuncture we collected 10-mL blood samples with lithium heparin anticoagulant, centrifuged (1000 x g, 10 mm) them, then separated and stored the plasma at -20 #{176}C until required. We used 50 samples of each of the pheno-
for these studies.
Benzoylcholine chloride as substrate.
For this assay we used the method of Kalow and Lindsay (14) and determined the dibucaine numbers and the fluoride numbers by the methods of Kalow and consists of separate reagents for "Chromogen" and "Substrate."
We made some adjustments to the reconstitution instructions, to compensate for the dilution by the inhibitor solutions. To prepare the working solutions, we dissolved the contents of a bottle of Chromogen in 50 mL of distilled water and the contents of a bottle of Substrate in 5.0 mL of distilled water (19). Plasma samples were used undiluted. 
Procedure
Mix 10-L aliquots of plasma in three cuvettes containing 1.0 mL of water, 1.0 mL of dibucaine solution, or 1.0 mL of sodium fluoride solution, respectively. Add 1.0 mL of"Chromogen" to each cuvette and incubate the mixtures for 5 mm at 30 #{176}C. Initiate the reaction by the addition of 0.1 mL of "Substrate" with immediate rapid mixing. Record the progress of the reaction for a period of about 3 mm at 410 rim, using the Multisampler attachment.
The instruction leaflet provided with the kit describes a procedure whereby the cholinesterase activity is obtained by measuring the time (t) for the absorbance of the test to increase by 0.100 and the enzyme activity is then calculated from the relationship: kUIL = 95.2/t.
For the purpose of this work, we found it more appropriate to calculate the total activity from the relationship: a/b = 1000 M/13 600t where a/b is the dilution, A the increase in absorbance recorded in t minutes and 13 600 the molar absorptivity of the 5-thio-2-nitrobenzoate ion, the product of the reaction (2) . The unit of cholinesterase activity (kUIL) is To complete the work, we also measured the enzyme activities and dibucaine numbers of the 150 samples at 25 #{176}C by the above procedure.
Results
Mean enzymic activities and standard deviations of the 50 different plasma samples for the three phenotypes studied with three different substrates are given in Table 1 for the three phenotypes studied but was a feature of the substrate used in the assays. With benzoylcholine substrate, the affinity of the usual homozygote E1t1E1t' for the fluoride ion was greater than that of the atypical homozygote E18E1a, and the affinity of the heterozygote E1UE1a was intermediate between the two homozygotes.
There was no realistic differentiation of the three variants by fluoride ion when propionylthiocholmne was the substrate under the current experimental conditions (Table 1) . With butyryithiocholine as substrate, the atypical enzyme has a much greater affinity for the fluoride ion than either the usual homozygote or the heterozygote; in this system, however, the latter two phenotypes were not clearly differentiatodat30#{176}C.
Discussion
One of the more attractive features of the use of propionylthiocholine as substrate for the assay of plasma cholinesterase activity is the apparent ability to differentiate Table 1 .
Specimens of plasma used in the current survey have not been selected with regard to succinylcholine sensitivity, but we have assumed that individuals having the phenotype E1aE18 will be sensitive to the drug. If we assume that individuals having an enzyme activity equal to or less than the maximum activity found in E15E1a individuals are sensitive to succinylcholine, we can predict the distribution of sensitivity among the other two phenotypes (Table 2 ). For example, of 100 E1"E1" individuals, 21 would be deemed sensitive if we use propionylthiocholine as substrate, an unacceptable finding in light of the data in Table 2 for the other substrates.
Our results may be unfairly biased by a single individual who showed a high enzymic activity with propionylthiocholine substrate; if we eliminate this individual and use the penultimate maximum activity as the baseline we find that, by using either of the thiocholines as substrate, we would consider no individuals of the phenotype E1'E1" to be sensitive to the drug; with benzoylcholmne as substrate, however, an unrealistic proportion of the usual homozygotes would be predicted to be sensitive. The criterion of "4 EU" (10) for propionyithiocholine is too high a baseline in our experience at 30 #{176}C (Table 2) , and we urge caution when using enzyme activity alone to predict succinylcholine sensitivity. Although physiological variation can influence enzyme activity (21), a true index of serum cholinesterase activity can be determined only at 37 #{176}C (24), regardless of the substrate used (9,22) .
The recognition of the relationship between the activity of cholinesterase and an individual's exposure to organophosphorus insecticides has resulted in the use of this assay not only to monitor the extent of exposure to these compounds but also to serve as an early diagnostic test before the clinical characteristics become apparent. For such use one must not rely on a single assay of the enzymic activity, #{176}Baseline recommended by Dietz et al. (10) at 37#{176}C for proplonytthiocholine.
Temp, "C thus, either both enzymes or the enzyme most readily inhibited by the organophosphorus compound to which the individual has been exposed should be deter-
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mined.
Regression equations from the experimental data for the conversion of dibucaine numbers obtained with different substrates are given with Figures 1, 2, and 3 , from which the order of substrate preference for the best differentiation of the variants appears to be: benzoylcholine > butyrylthiocholine > propionylthiocholine.
As shown by the considerable overlap of dibucaine numbers of the E11'E1"and E1)lE1a phenotypes at 30#{176}C, with either propionylthiocholine or butyrylthiocholine the temperature of the assay can play an important part; these variants become better segregated with butyrylthiocholine when the assays are carried out at 25#{176}C (Figure 4) , in confirmation of the observations of King (24) . There is complete segregation of phenotypes at 25 "C with benzoylcholine substrate and dibucaine as the differential inhibitor (Figure 1) .
It is useful to compare the results of other laboratories that use dibucaine numbers for the identification of phenotypes. These data, summarized in The apparent inversion of affinities of the two homozygotes for the fluoride ion in the presence of different substrates may be related to the temperature of the assay system, 30#{176}C being used with butyrylthiocholine and 25#{176}C with benzoylcholine.
Although fluoride inhibition is known to be temperature dependent (15) , it is inconceivable that the small (5#{176}C) temperature difference between the two assays could account for the apparent anomalous inversion of fluoride inhibition with the two substrates. Das and Liddell (6) showed that similar fluoride inhibitions of cholinesterase variants were obtained with acetylthiocholine at 5 mmolJL or butyrylthiocholine at 7.5 mmol/L at 25 #{176}C, our combined results suggest that the inverted fluoride inhibition characteristics could be due to either substrate or some modifring effect of DTNB in the presence of substrate or phosphate ion. Garry (25) has indicated that use of sodium fluoride as a differential inhibitor of the cholinesterase variants gave conflicting results, depending on the choice of buffer in the assay in which a thiocholine ester was the substrate. He showed that, whereas the usual homozygote had the same activity in either Tris buffer or phosphate buffer (50 mmol/L, pH 7.4), the atypical homozygote was appreciably inhibited by the phosphate ion as compared with the same assay in a Tris buffer system. We suggest that the fluoride ion is the inhibitor in Tris buffer, whereas a fluorophosphate may be the true inhibitor in phosphate buffer. Cations have also been shown to have a greater effect on the atypical enzyme than on the usual enzyme (25,26), but an explanation in terms of either phosphate buffer or ionic effect cannot explain these anomalies, the experimental conditions in this study with respect to temperature and buffer for the benzoylcholine method being effectively the same as those used by Das and Liddell (6) for butyrylthiocholine. Thus the effect of varying concentrations of DTNB on the two variants with benzoylcholine as substrate seems worthy of investigation.
During this study we have not attempted to investigate the differentiation of the fluoride-resistant variants, which are best identffied in a reference laboratory (15) .
We have found the butyryithiocholine Merckotest method convenient for the determination of dibucaine number. Moreover, its satisfactory performance is indicated by the good agreement between the results of single assays for the Merckotest and the means of two assays reported for each of the two reference methods. However, in agreement with the as-yet-unexplained phenomenon reported by Garry (25), we confirm that it is not at present satisfactory for the determination of fluoride number.
